SLC18A2 and Parkinson disease: As early as 1989, by analysing vesicular monoamine transporter 2 (VMAT2) binding during ageing in PD and healthy subjects, Sherman et al. provided the first evidence indicating that PD symptoms appear when the striatal denervation state is over a critical threshold of about 50% [82, 93, 94].